Therapy for Stage IV Non-Small-Cell Lung Cancer With Driver Alterations
Publication Date: May 30, 2024
Last Updated: May 30, 2024
Treatment
Summary of All Recommendations
NOTE:
- For recommendations with multiple treatment options of the same evidence quality and strength of recommendation, the decision of which agent to offer should be tailored to each patient incorporating both efficacy and toxicity.
- All biomarkers should be available at the time of decision-making.
Title
Therapy for Stage IV Non-Small-Cell Lung Cancer With Driver Alterations
Authoring Organization
American Society of Clinical Oncology